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Abstract: 
We present a benchmark pilot study in which high-resolution Full-Field Optical Coherence 
Tomography (FF-OCT) is used to image human breast tissue and is evaluated to assess its ability to 
aid the pathologist’s management of intra-operative diagnoses. Our aim included evaluating the 
safety of FF-OCT on human tissue and determining the concordance between the images obtained 
with routinely prepared histopathological material.   
The compact device used for this study provides a 1.5 μm-lateral and a 1 μm-axial resolution, and is 
able to scan a 1.5cm² specimen in about 7 minutes. 75 breast specimens obtained from 22 patients 
have been imaged. Because the contrast in the images is generated by endogenous tissue 
components, no biological or chemical contrast agents or specimen preparation are required. 
We characterized the major architectural features and tissue structures of benign breast tissue, 
including adipocytes, fibrous stroma, lobules and ducts. We subsequently characterized features 
resulting from their pathological modification and developed a decision tree for diagnosis. Two 
breast  pathologists applied these criteria, resulting in a demonstrable ability to distinguish between  
normal or benign tissue, in situ  and invasive carcinomas using FF-OCT images, with a sensitivity of 
97% and 90%, respectively, and specificity of 74% and 77% respectfully. 
FF-OCT shows great potential for the evaluation of human tissue and its characterization as 
normal/benign vs. lesional, for numerous ex-vivo clinical use-cases. Its high imaging accuracy for in-
situ and invasive carcinoma paves the way for applications where a fast architectural assessment 
could improve the core needle biopsy workflow and tumor margin assessment.  
 
Introduction:  
 Breast cancer remains the second leading cause of cancer death in women in the United 
States, with an estimated 232,620 new cases and 39,970 breast cancer deaths (39,520 women, 450 
men) expected in 2011 (1). Nevertheless, in many countries, thanks to more systematic screening 
and better treatment regimens, breast cancer mortality has steadily decreased since 1990, with a 
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decrease of 3.2% per year in women younger than 50 and of 2% per year for women 50 and older (1). 
Earlier screening allows for the detection of small invasive lesions and in situ carcinomas. For these 
lesions, breast-conserving surgery (lumpectomy) is standard practice, along with axillary sentinel 
node biopsy, in cases of invasive carcinoma.  
Prior to definitive curative surgical therapy, routine diagnostic evaluation, usually with needle core 
biopsy and/or fine needle aspiration, has obviated the need for lesional diagnostic frozen section 
analysis at the time of surgery (2). In fact, for very small tumors, some have suggested that frozen 
sections may even be inappropriate for lesional diagnosis (3). However, frozen section analysis may 
still be performed to assess surgical margins, in an effort to minimize the need for a second surgical 
procedure. Unfortunately, frozen section analysis reportedly only has an overall sensitivity of 73% (4-
5) and is associated with several drawbacks: it is time consuming (20-30min) (6), highly operator 
dependent, destructive to the sample as part of the tissue is lost during slide preparation, allows for 
only limited sampling, and introduces freezing artifacts (7-11) that significantly hamper 
interpretation. Alternative techniques for immediate assessment of specimen margins, such as touch 
prep cytology (12) or intraoperative radiography (13), are also fraught with disadvantages, including 
poor sensitivity, limited spatial resolution, and added time. As a result, the re-excision rate is typically 
20%, and may be as high as 40% (5-6, 14-19). Consequently, improvements in the ability to perform 
accurate intra-operative margin assessment using a sub-surface optical microscopic technique is 
attractive, particularly if it is easy to perform, operator independent, non-destructive, fast, and 
provides for high enough spatial resolution that can mimic traditional histopathological analysis.  
Successful optical microscopy has been achieved on excised skin (Mohs surgery) using confocal 
microscopy (20) and multiphoton microscopy (21). However, the need for  large numerical aperture 
objectives to “virtually slice” the tissue makes confocal microscopy sensitive to tissue-induced 
aberrations as well as to the effects of multiple scattering. Alternatively, optical sectioning 
techniques using Optical Coherence Tomography (OCT) (22) with a deep red or near infrared sample 
illumination offers many advantages: they are safe, non destructive (no biological or chemical 
modification), and do not require any exogenous contrast agents that could potentially compromise 
the tissue integrity for subsequent routine histopathological preparation or molecular testing. In the 
current study, we use the Full-Field OCT (FF-OCT)(23-24) technique to provide large fields of view and 
high resolution images of unprocessed breast specimens. 
Comparison of FF-OCT to other current imaging techniques 
The principal imaging techniques comparable to FF-OCT are traditional OCT (22), confocal microscopy 
(25), and Optical Coherence Microscopy (OCM) (26).  
Numerous studies have been published during the past few years, demonstrating the suitability of 
OCT imaging for both in vivo and ex vivo tissue diagnosis.  OCT has been previously investigated in a 
variety of tissues such as the eye (27-29), upper aerodigestive tract (30-33), gastrointestinal tract (34), 
breast tissue and lymph nodes (35-41). One of the earliest studies on human breast tissue showed 
that benign and malignant lesions could be differentiated using “Ultrahigh Resolution and Three-
dimensional Optical Coherence Tomography” (37), which correlated OCT images with 
histopathological findings for ductal carcinoma in situ, invasive cancer and micro-calcifications. 
Another study (38), based on spectral-domain OCT, focused on the assessment of breast tumor 
margins and demonstrated good sensitivity and specificity. However, this study, involving a 
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significant number of patients and images, is specific to tumor margin evaluation and uses diagnostic 
criteria based on “large scatterers” and not on the microscopic morphology. Both these studies of 
breast tissue utilized techniques that had a limited spatial resolution: the former obtained a 6 μm 
transverse resolution and 3.5 μm axial resolution, while the latter obtained a 6µm axial resolution 
and 35µm transverse resolution. Unfortunately, at these resolutions, OCT images appear fuzzy 
compared to conventional histology. Indeed, in order to satisfy pathologist’s requirements, the 
optical technique must mimic that seen with traditional histology : typically a field of view must be 
larger than a cm2 and the smallest details (spatial resolution) should be closer to 1 μm.  
Technically , the FF-OCT setup, described in details in the methods section below, uses immersion 
microscope objectives with a numerical aperture of 0.3. This is in contrast to typical  OCT setups in 
which the numerical aperture is one order of magnitude lower (42)  therefore the light scattered by 
small sized structures smaller than the wavelength is between 10 (for fiber type ones)  and 100 (for 
3-D structures times weaker and are missing in low aperture images; yielding OCT images with 
resolution and contrast that is comparatively much lower than FF-OCT images.  
Furthermore, as it is described in the following section, FF-OCT uses “en face” acquisition of the 
images. Due to this “en face” acquisition , FF-OCT offers by far the best lateral resolution. Indeed FF-
OCT can work without the large depth of field required for time domain, spectral domain, Fourier-
domain or swept-source OCT. For these non FF-OCT methods, the available depth range must be of 
the same order as the depth of field of the objective, therefore requiring low numerical aperture 
optics, which consequently limits the lateral resolution capability to typically 5 to 40 µm. In contrast, 
the lateral resolution of FF-OCT is comparable to Optical Coherence Microscopy (24), but its axial 
resolution is better than what could be obtained using super-fast lasers, while facilitating more 
flexibility and a better ability to capture a large field of view.            
Improved resolution has recently been accomplished by combining two techniques: OCT, with its 
large field of view, and Optical Coherence Microscopy (OCM) with its maximum lateral resolution of 2 
μm (26). By doing so, it was possible to achieve high-resolution images of small zones with a 
sectioning ability (axial resolution) of 4 μm. With this improved resolution, the comparison of images 
with conventional histology of breast tissue is striking, providing an ability to distinguish adipose 
tissue, fibrous stroma, breast lobules and ducts, as well as in-situ and invasive carcinomas. For that 
study,  the field of view of OCM was limited to 400x400µm2, utilizing a femtosecond ND:glass laser 
The large field images can only be obtained using the low axial (4µm) and transverse (20µm) 
resolution of the OCT system; at this resolution breast structures appear blurry. High resolution 
images can only be obtained by switching to OCM which then limits the field of view to 400x400µm2 . 
Other limitations to the study included the inability to carry out accurate statistical analysis of 
sensitivity and specificity due to few specimens and an inability to determine detection accuracy of 
the new imaging technology due to non-blinded evaluation of the images.  
Pathologists need to be able to identify a zone of interest for assessing the malignancy of a breast 
specimen. However, with the low resolution of the large field image it can be difficult to identify the 
correct zone of interest and the tiny field of view when using OCM represents a major drawback for 
implementation in the clinical setting.  
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In addition, the cost  of an adequate femtosecond laser remains very high. Although laser technology 
continues to improve, these lasers remain expensive, often costing as much as the rest of the OCM 
setup. Large peak power at the focus of ultra fast laser can induce high order photobleaching, similar 
to what has been observed using 2-photon fluorescence (43). Other endogenous chromophores, 
such as melanin can limit tissue imaging by causing thermal and mechanical damage during an 
experiment. Finally using lasers requires supplementary safety requirements. For these reasons, 
OCM is not the best method to use for all tissue imaging application. 
Confocal microscopy (CM) produces high resolution images but the imaging depth is markedly 
limited. Whereas FF-OCT can show clear signals (contrast and resolution) down to 200µm in depth 
for fat and 150µm in depth for fibrous tissue, the depth is limited to about 50µm with a confocal 
microscope.  
FF-OCT allows a pathologist evaluating large fields to scan the entire biopsy specimen and to follow 
the morphology at different scales and different positions. The Full-Field OCT (FF-OCT) technique 
accommodates imaging of unprocessed tissue samples down to 200 μm below the specimen surface 
(depending on the type of tissue), over a large field of view that allows zooming in on specific areas 
down to the micron scale. More importantly, it should be emphatically noted that no exogenous 
contrast agent nor any chromophore is required for imaging, as specimens are excised from 
mastectomy pieces and can be analyzed fresh without fixative and directly imaged with no further 
preparation. Utilization of FF-OCT for imaging of both fresh and fixed animal tissue has already 
proven its suitability and performance for high-resolution, large field images (44). 
The main objective of this study is to evaluate whether the images obtained with FFOCT contain 
sufficient morphologic details that is adequate for a pathologist to make a suitable diagnosis, 
comparable to that which would be rendered using traditional histological techniques. Specifically, to 
assess the ability to identify various tissue structures, the ability to assess if an area is “normal” or 
contains “pathology”, and the ability to identify specific histological patterns characteristic of 
common pathological entities.  
We aim to show in the present study that tissue characterization is now possible. 
Material and Methods: 
Instrument: 
OCT (22) is a unique technique for imaging scattering media such as biological tissues, by 
interferometric selection of ballistic photons. It has proved to be an invaluable tool for biomedical 
imaging. In contrast with most of the available OCT approaches (e.g. time domain OCT or Fourier 
domain OCT), FF-OCT directly takes "en face" images using megapixel cameras and microscope 
objectives. In our setup, a very compact and stable interferometer is displaced to move the focal 
plane at different depths below the surface and to generate 3D tomographic images(45). En face 
capture allows FF-OCT to operate with high lateral resolution (typically ~1µm) using medium to large 
aperture microscope objectives (46). Nevertheless, the penetration of the beam into the volume of 
the sample induces a shift between the focus and the sectioning plane due to refractive index 
mismatch. In order to compensate for this phenomenon and the aberrations that may take place, a 
real time optimization of the signal is achieved (47).    
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The principle of FF-OCT relies on low coherence interference microscopy. The experimental 
arrangement of FF-OCT (Figure 1) is generally based on a configuration that is referred to as a Linnik 
interferometer (48). A halogen lamp is used as a spatially incoherent source to illuminate the whole 
field of a immersion microscope objective. Due to the low temporal coherence of the source, 
interference occurs only when the optical path lengths of the two-interferometer arms are identical 
within typically 1µm, which is equal to the effective coherence length of the source (taking into 
account the camera spectral response) divided by 2n, n being the refractive index of the sample. 
When a biological object is placed under the microscope objective in the object arm, the light 
reflected by the reference mirror interferes with the light reflected or backscattered by the sample 
structures contained in a limited volume that is a slice orthogonal to the objective axis, located at a 
depth inside the object defined by an optical path length difference of zero. The signal is extracted 
from the background of incoherent backscattered light using phase-shifting method.  
Taking “en face” images allows an easy comparison with histological sections. The resolution, pixel 
number and sampling requirements results in a field of view that is limited to about 1mm2. Histology 
sections are typically ~1 cm2 and a pathologist typically evaluates tissue at several magnifications 
where field of view varies from cm down to μm, in order to make a reliable diagnosis. For this reason, 
we move the sample on a high precision mechanical platform and we stitch a number of images to 
display a significant field of view (49).The FF-OCT technology is utilized to build a compact setup (fig 1) 
that is about the size of a standard optical microscope (310x310x800mm L x W x H) and for this study, 
was located in the laboratory room used for frozen section analysis (Figure 1B). It is quiet and does 
not create any unwanted heating, lighting or sound in the room. 
Imaging protocol:  
Written consent was obtained prior to imaging according to the standard procedure in the hospital 
Tenon (Paris) for each patient undergoing biopsy or surgical resection.  
 Sample selection: 
For each patient we imaged at least 4 tissue samples, each averaging 1-1.5cm2: one sample from the 
tumor, one at the edge of the tumor, and 2 samples from adjacent normal appearing parts of the 
specimen. Gross examination alone was used to identify the tumor. The size of the tissue samples in 
this study is considered comparable to the size of those typically acquired and used for frozen section 
analysis. 
Sample preparation 
The sample tissue was placed in a sample holder and immersed in a saline solution. A specially 
designed cover slip was carefully placed on the specimen in order to create a flat surface and to 
reduce optical aberrations. The specimen was raised and gently pushed against the cover slip by 
displacing the sample holder piston. The holder was then placed under the immersion objective of 
the microscope. Optical oil was added on top of the cover slip to ensure a continuous optical path. 
The specimen is then protected from the environment and is isolated from the air and the objective 
immersion liquid. 
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 Image acquisition:   
After the FF-OCT imaging procedure, the samples were fixed in formalin and subjected to routine 
processing including paraffin embedding, sectioning and HES staining at the same estimated depths 
than the imaging depth. For consistency, our comparison between images acquired by FF-OCT and 
histology preparations has been primarily performed with images taken at 20µm below the cover slip, 
since this depth corresponds to the least attenuated signal on the FF-OCT images and the most 
representative sections of the paraffin embedded block. Nevertheless, as noted above,  signal from 
breast specimens is detected up to 150µm for the fibrous part and up to 200µm for the fat one. 
All FF-OCT images were taken using a non-inversed linear look up table (LUT) scale. Thus, the hypo-
scattering structures appear black, whereas the hyper-scattering structures appear white. 
In most cases, in order to facilitate the comparison with HES stained slides, the entire tissue sample is 
imaged. The resulting slides were then scanned to produce whole slide images for use as 
comparative images.  
Study protocol: 
75 breast specimens were imaged from 22 patients (21 women, 1 man) with a mean age of 58 (range 
25-83). A total of 193 images were acquired. In most cases, samples were selected from freshly 
excised and fixed radical mastectomy specimens, e.g. large malignant or multifocal tumors, benign 
macroscopic lesions and/or normal appearing tissue present in other areas of the same breast.  
Images on fresh tissue offer a better contrast, and all figures in this manuscript are from fresh 
specimens. Nevertheless images from fixed specimens were easily interpretable by the pathologists  
and we included images from both fresh and fixed specimen in the sensitivity and specificity study. 
The samples included normal appearing tissues as well as a large range of breast lesions from men, 
post- and pre-menopausal women. No discrimination has been made regarding the patient’s age or 
health status, therefore allowing for inclusion  the broadest selection  of breast tissue and 
verification that malignancy assessment could be made on any type of tissue.  
In most cases, samples were selected from freshly excised radical mastectomy specimens, e.g. large 
malignant or multifocal tumors, benign macroscopic lesions and/or normal appearing tissue present 
in other areas of the same breast. A selection of the cases to be sampled was made in order to be 
able to image a larger amount of different lesions with different macroscopic appearance (nodular or 
stellate) and different histological types of invasive carcinoma. This information was available from 
pre-operative diagnoses (mammography and needle core biopsy). Most patients had more than one 
diagnosis classification associated with their histopathological assessment.  
The study was conducted in three phases: 
Phase 1: The safety of FF-OCT on human breast tissue was evaluated. Samples were imaged and then 
processed for routine  standard histopathology. The specimens imaged by FF-OCT were assessed for 
any adverse impact on tissue architecture revealed by HES staining or on immunophenotype 
assessed by immunochemistry. 
Phase 2: The goal of this phase was to highlight the main architectural features of human breast 
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tissue in our images, by comparing these images with standard histopathology slides prepared from 
the same specimens. This phase facilitated the delineation of the main architectural features seen in 
human breast tissue, which can be utilized to interpret and characterize the normal/benign and 
malignant nature of the lesions.  
Phase 3: Pathologists were blinded to final histological diagnosis, and were asked to determine based 
on the FF-OCT image features alone if the specimen was normal/benign or malignant. They receive 
no macroscopic images of the samples and did not review the histological slides or whole slide 
images produced from them. The test was conducted long after surgery to prevent any possible 
familiarity with the case, and the pathologists had no pre-operative assessment information for any 
of the patients. 
Results: 
Final histopathological diagnoses included 3 cases of invasive lobular carcinoma, 7 cases of invasive 
ductal adenocarcinoma, 6 cases of lobular carcinoma in situ, 6 cases of ductal carcinoma in situ, 1 
case of invasive mucinous adenocarcinoma and 1 case of ductal hyperplasia. 
Phase 1: Safety 
Samples were imaged using FF-OCT under conditions used in phases 2 and 3 described below.  
Six additional radical mastectomy specimens were included in this part of the study. After imaging 
procedure, tissue architecture was assessed by gold standard histopathology and compared to 
histological sections corresponding to other specimens of the same region of the breast that did not 
follow the imaging procedure.  
In the case of carcinoma specimens, usual markers tested by immunohistochemistry (IHC) involved in 
tumor evaluation were quantified in order to verify that FF-OCT imaging procedure does not alter the 
parameters usually tested.  Thus, the signal of Estrogen and Progesterone receptors, Cerb B2 
(Her2/neu), ki-67 and  E-Cadherin was evaluated and quantified on tumor samples that were imaged 
with FF-OCT and compared to tumor samples from the same patient that did not follow the imaging 
procedure.  
In the case of normal breast tissue specimen, the signal of other IHC markers such as cytokeratin(CK) 
7, 14, 18, 5/6 and vimentin was evaluated and quantified on samples imaged with FF-OCT. The signal 
obtained was compared to their usual expected signal on normal breast tissue. 
After comparison, the value of the different markers for evaluation of the tumourous specimens 
imaged with FF-OCT were the same as those obtained with matched control specimens from similar 
regions of the specimen that were not imaged with FF-OCT prior to processing.  
For normal breast tissue, the localization of the signal of the different types of CK and vimentin was 
the same as the expected signal on normal breast tissue. 
Therefore, we have shown that no alterations in any of the parameters assessed (histopathology and 
immunohistochemistry) were observed due to FF-OCT procedure.  
The total acquisition and image rendering time for a 1,5cm² breast specimen is 7 minutes. Sample  
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positioning in the sample holder and initialization of the device is 5 minutes long. Together, these 
make up to the complete imaging procedure requiring only 12 minutes, significantly shorter than 
what is typically required for frozen section analysis (20-30 min).  
Phase 2 : Correlation of the morphologic features in FF-OCT images with gold standard 
histopathology 
Part 1 : Breast tissue characteristics recognition 
After safety assessment of this technique, we focused on distinguishing morphologic features 
expected in breast tissue on FF-OCT images. This analysis also provided study pathologists with an 
opportunity to familiarize themselves with the images. We focused on morphological features that 
were distinguishable in whole slide images of conventional histological preparations and FF-OCT 
images. 
By conducting a comparative analysis with normal breast tissue, we (MA and BSZ) were able to   
recognize and characterize morphologic features of the major components of breast tissue in the FF-
OCT images, including fibroadipose tissue, epithelial ducts, vasculature and fibrous tissue (Figure 2). 
For example, we found that the galactophorous ducts, when cut tangentially, are recognizable by 
light grey color, which we hypothesize is generated by their highly scattering thick elastic membranes 
(Figure 2C). In contrast, the same glands, when cut longitudinally, exhibit a characteristic epithelial 
layer of varying thickness that appears dark grey (Figure 2B). Intraluminal secretions are sometimes 
identified. The lobules (Figure 2A) are identified as dark grey granular rounded structures. The 
vessels (Figure 2D), when cut tangentially, do not have the thick epithelial layer of the 
galactophorous ducts, but are also associated with the presence of an elastic membrane. The 
adipocytes (Figure 2E) are hypo-scattering, and appear as black rounded structures. Their 
membranes produce more scattering and appear grey. The characteristic honeycomb configuration 
of the fat cells is easily identified. The healthy fibrous tissue appears grainy with medium back-
scattering signal (Figure 2G). The fibrous tissue in the stroma is made of hyper-scattering trabeculae 
(Figure 2H). The scar fibrous tissue is made of thick and large trabeculae, less scattering than the 
stroma. Calcifications appear white (Figure 2C) due to their very high backscattering levels.  
The high resolution of the FF-OCT technique enables the visualization of the very thin membranes of 
the vessels and those of the adipocytes (Figure 2D, 2E).  
Our large scale images display most of these structures that define our grey scale: dark equals 
absence of tissue or adipocytes, white equals fibrous and dense tissue. 
 
Part 2: Distinction between benign/normal and malignant tissue 
After gaining an understanding of the normal morphologic features of human breast tissue 
appearance in our images, we next focused on discerning what aberrations of these morphologic 
features images would facilitate characterization of the tissue as benign/normal or malignant. The 
analysis produced a distinct set of criteria that needs to be satisfied for accurate distinction between 
benign/normal and malignant tissue, along with a recommended workflow that should be followed 
to make the determination. The workflow and criteria are presented as a flowchart in (Figure 3), and 
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briefly outlined below. 
1) First, assess the FF-OCT images using the criteria used for low magnification assessment of 
standard histology slides. These would include features such as the presence or absence of stellate 
lesions, and the entanglement of the adipose and fibrous tissues. 
2) If there is no evidence of tumor at low magnification, it is necessary to verify the presence of intact 
normal breast tissue structures such as lobules, galactophorous ducts and vessels. 
3) If there is no obvious tumor and there is no evidence of intact normal structures, the following 
criteria for reading the FF-OCT images must be used. 
 a) Assess the shrinkage of the adipose tissue, which is characterized by the presence of 
adipocytes of different sizes at the periphery of an invasive carcinoma. In most cases, at the interface 
of the lesion, fat cells appear smaller and less rounded.  
 b) Search for the presence of grey zones, typically surrounded by white fibrous structures 
(corresponding to foci of carcinoma surrounded by fibrous tissue). 
 c) Assess the color and the morphology of this fibrous tissue. The appearance of the fibrous 
tissue is different depending on the type of collagen present.  In FF-OCT images, the fibrous tissue of 
malignant tumor-associated stroma is very white, while it is greyer for scar-associated fibrous tissue 
or normal/benign breast fibrous tissue. Furthermore, the fibrous tissue architecture differs, usually 
appearing as thin trabeculae in malignant tumor associated stroma, while appearing as thick 
trabeculae associated with reactive/reparative change (i.e. wound tissue) (Figure 2F). Trabeculae are 
not seen in normal or benign fibrous tissue (Figures 2F, 2G, 2H).  
 
Figure 4 consists of an image from normal breast tissue of a post-menopausal woman and the 
comparable whole slide image of the conventional gold-standard histology preparation. The image 
shows the characteristic structures of breast tissue such as the lobules, galactophorous ducts, 
adipocytes and a normal fibrous tissue. There is some entanglement of the fibrous tissue and adipose 
tissue noted.  
The fibrous tissue appears grainy with a medium back scattering level. Ducts are cut longitudinally; 
thus they look dark grey. Digital zooming of the image reveals acini in the lobules.  
Next, in Figure 5, two types of invasive carcinoma can be seen: a stellate tumor (Figure 5A-B) and a 
nodular one (Figure 5F-G). In both lesions, the trabeculae of the highly scattering tumor-associated 
fibrous tissue can be observed (Figure 5D, 5H). This is contrast to the normal fibrous tissue that 
appears grainy and produces less scattering (Figure 5I). Furthermore, tumor-associated adipocytes 
are smaller than the ones outside of the tumor (Figure 5E). In the stellate tumor (Figure 5B), the 
fibrous tissue is seen invading the adipose tissue. In the nodular tumor (Figure 5G), foci of carcinoma 
cells appear as grey zones surrounded by the highly scattering tumor-associated fibrous tissue 
trabeculae (5H). A circular dilated duct with secretion in the lumen is visible in the center of the 
nodule. The different aspect of fibrous tissue defines the tumor margins on Figure 5G.  
Figure 6 shows an invasive ductal adenocarcinoma with an associated ductal carcinoma in-situ (DCIS) 
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component. Enlarged lobules and ducts filled with DCIS (Figure 6C, 6D) are clearly visible on the 
image. In addition, the invasive component is characterized by the presence of highly scattering 
fibrous tissue (Figure 6B) and foci of darker grey carcinoma cells (Figure 6D). 
 
A fibroadenoma is shown in Figure 7D and the enlarged ductules (Figure 7E) characteristics of this 
benign lesion are easy to distinguish in the FF-OCT image. DCIS is noted in Figure 7A, characterized by 
enlarged abnormal lobules (Figure 7C) and ducts (Figure 7B), which can be distinguished easily by 
digital zooming of the image. The acini in the enlarged lobule are clearly visible and the narrow 
lumen in the duct is indicative of malignancy.  
Phase 3: Assessment of the diagnostic accuracy of FF-OCT 
Using the above-mentioned workflow and criteria set, 70 and 73, respectfully, breast tissue sample 
images were reviewed by 2 senior-staff breast pathologists (MA and BS). In isolation of the 
histopathology or medical history, each classified the images into two diagnostic categories: 
normal/benign or malignant. Following completion, their designations were compared to the 
diagnosis based on the gold-standard histopathology preparations of the same tissue used to 
produce the FF-OCT images. The analysis of the first breast pathologist (MA) yielded 28 true positives, 
30 true negatives, 3 false negatives and 9 false positives, giving a sensitivity of 90% and a specificity 
of 77%. The analysis of the second breast pathologist (BSZ) yielded to 30 true positives, 28 true 
negatives, 1 false negative and 14 false positives giving a sensitivity of 97% and a specificity of 74%.  
Note that for each pathologist, a few images (5-MA, 2-BSZ) were considered uninterpretables, 
primarily due to a non optimal positioning of the sample under the glass plate used with the sample 
holder, thus resulting in acquired images at a depth at which the whole sample area was not optically 
sliced and therefore not entirely visible on the resulting image.  
 
Discussion: 
In this benchmark pilot study, we describe the first pre-clinical evaluation of FF-OCT for ex-vivo 
human breast tissue analysis and its ability to facilitate interpretation for tissue diagnosis. First, we 
have shown that the technique is safe, producing no demonstrable alterations that affect 
interpretation of conventional histology preparations following imaging, or any alteration in the 
ability to perform immunohistochemistry for a variety of epitopes. Next, using the images produced, 
we have demonstrated an ability to assess the microstructure of normal human breast tissue 
including glands, lobules, galactophorous ducts, and adipose tissue. Lastly, we have developed a set 
of initial criteria and a recommended workflow for interpreting FF-OCT images which can accurately 
differentiate whether the alterations observed are benign/normal or malignant. In many cases, a 
specific histopathological diagnosis can be made by the pathologist, such as invasive carcinoma,  
carcinoma in-situ, and benign fibroadenomas.  
FF-OCT is the first ultra-high resolution optical imaging technique that combines the possibility of 
obtaining breast tissue images over an adequately large area, while producing images of sufficiently 
high resolution, thereby allowing pathologists to mimic routine histopathology diagnostic workflow 
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by zooming in and out on the images. We have established a diagnostic decision tree, which would 
allow pathologists to classify tissue as malignant or benign/normal. While the values obtained for 
sensitivity and specificity could indeed be improved, it is important to note that this diagnostic 
accuracy assessment was totally blinded to any clinical information or context, and that the breast 
tissue remains a very complex organ, with numerous potential histopathological entities. 
While the current study has only a limited sample size, and concentrates on a single organ system, 
the lessons acquired from this initial pilot study will help with the design of future evaluations of 
tissue samples from all the major organ systems.  
We propose that in its current stage of development, FF-OCT imaging technique has great potential 
for several use cases. First, it represents a paradigm shift in the handling of immediate assessment of 
resected tissue. For the first time, it allows for primary digital acquisition of enough information to 
allow pathologist to meaningfully interpret the morphologic features of tissue, on fresh tissue in a 
non-destructive manner. The lack of need for sample preparation and rapid image capture has the 
potential to significantly reduce the time it takes to provide this interpretation surgeons. For certain 
types of frozen sections, such as margin assessment, it has potential to diminish the need for a re-
excision and improve post-operative prognosis. Because it is non-destructive, it has great potential to 
far exceed our current ability to perform both immediate and routine assessment of high risk, small 
biopsy specimens, such as those obtained from central nervous system tumors. In fact, it could be 
used to carry out immediate or permanent assessments of tissue biopsies in a variety of contexts. For 
a typical core needle biopsy with a surface area of 0.2 cm², imaging can be accomplished in about 1 
minute. This would then allow for additional testing of the tissue, particularly in cases where fresh 
non-fixed, non-paraffin embedded tissue is required.  
In vitro application of this technology may also be evaluated for both clinical and research tissue 
banking (where tissue is cryopreserved for future use, such as DNA or RNA extraction). In oncology, 
the diagnosis and treatment of tumors frequently requires molecular diagnostic information (i.e. 
gene mutations, translocations, amplifications) to inform targeted therapy. The optimization of these 
techniques on small biopsy samples is crucial for the pathologist, the clinician and the patient, 
particularly those who have advanced or metastatic, and thus inoperable, cancer. The fact that the 
FF-OCT technology does not consume the tissue and does not induce alterations is a real advantage. 
Moreover, the standard procedures in a typical pathology laboratory (e.g., embedding tissue, 
sectioning of a paraffin-embedded tissue with the microtome, frozen section preparation with a 
cryostat) are still not automated. Thus, these procedures are time consuming and require expert 
technical personnel. However, it is now possible to foresee the pathology laboratory of the near 
future, where “triaging” of specimens by FF-OCT could significantly streamline the workflow, such 
that only truly important specimens are paraffin-embedded and processed for gold standard 
histopathology.  
Finally, in vivo application of FF-OCT technology for endoscopic evaluation will be very helpful for 
clinicians and surgeons. By utilizing FF-OCT endoscopy, the clinician and pathologist can better 
evaluate the nature of a suspicious lesion, providing better targeting for areas to sample, decreasing 
non-diagnostic specimens reaching the lab for conventional histopathological assessment. Such 
applications are foreseeable for cancers of the respiratory tract, the gastrointestinal tract, the urinary 
tract and the male and female reproductive tracts. During many of these procedures, for example, 
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the surgeon is unable to palpate the organ directly, limiting their ability to appreciate tactile nature 
of the possible neoplasm. Consequently, we have recently developed a 2mm-diameter rigid probe 
and are currently obtaining preliminary results on in vivo breast tissue imaging with this experimental 
setup (50). 
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Figures: 
Figure 1 : 
Figure 1 : FF-OCT experimental setup  based on a Linnik interferometer configuration (1A). Compact set-up 
used for the study (1B)   
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Figure 2 : 
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Figure 2 : Breast tissue basic structures:  lobule(A), galactophorous duct (B), cross section of a galactophorous duct with calcifications (C), 
vessel (D), adipocytes (E). Scar fibrous tissue (F), normal fibrous tissue (G), fibrous tissue surrounding carcinomatous cells in tumourous 
stroma (H). Images were acquired at 20µm beneath the tissue surface.
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Figure 3 : 
Figure 3 : Diagnosis decision tree for FF-OCT images on  human breast tissue
 
 
Figure 4 : 
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Figure 4 : Healthy breast tissue specimen.  FF-OCT image was acquired at 20µm beneath the tissue surface.
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Figure 5 : 
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Figure 5 : Different types of invasive adenocarcinoma : stellate  (A) and nodular (B). FF-OCT Images were acquired at 20µm beneath the tissue 
surface
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Figure 6 : Ductal invasive adenocarcinoma with ductal Carcinoma in situ (DCIS) component. FF-OCT Images were acquired at 
20µm beneath the tissue surface
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Figure 7 : 
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Figure 7 : Ductal carcinoma in situ (A ) with an abnormal duct (B) and an enlarged lobule (C). Fibroadenoma (D) and an enlarged ductule
(E). FF-OCT images were acquired at 20µm beneath the tissue surface.
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